HALO logo
halo search icon
Insulet Corporation

US$156.59

Price Change Indicator
1.98 (1.28%)
Insulet Corporation
PODD · NAS

Insulet Corporation

Start Trading PODD for Free

US$156.59

Price Arrow1.98 (1.28%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO 500HALO AllHALO Capital EfficiencyHALO GARPHALO Small+3
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Insulet Corporation Overview

PODD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Neutral

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Strong

About PODD

icon
icon

Telephone

1.978.600.7000

icon

Address

100 Nagog Park, Acton, MA 01720

Description

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

PODD Price Chart

Key Stats

Market Cap

US$10.71B

PE

81.70

EV/EBITDA

35.2

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 145.59 - 354.88

Trade Value (12mth)

US$56,165,798.00

1 week

4.85%

1 month

-19.61%

YTD

-45.35%

1 year

-52.35%

All time high

354.88

Key Fundamentals

EPS 3 yr Growth

5197.90%

EBITDA Margin

21.70%

Operating Cashflow

$569m

Free Cash Flow Return

22.60%

ROIC

9.80%

Interest Coverage

7.40

Quick Ratio

2.10

Other Data

Shares Outstanding (Fully Diluted)

70m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PODD Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
06 May 26
06 May 26
30 April 26

PODD Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock2.965.973.51locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.945.783.48locklocklock
Growth
 %locklocklocklock4,361.1101.8-41.2locklocklock
PE
 Xlocklocklocklock73.745.181.7locklocklock
EV/EBITDA
 Xlocklocklocklock5748.335.2locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Insulet Corporation (PODD:NAS)?
Halo FAQ
The current share price of Insulet Corporation (PODD:NAS) is USD$156.59.
What is the 52-week high share price for Insulet Corporation (PODD:NAS)?
Halo FAQ
The 52-week high share price for Insulet Corporation (PODD:NAS) is USD$354.88.
What is the 52-week low share price for Insulet Corporation (PODD:NAS)?
Halo FAQ
The 52-week low share price for Insulet Corporation (PODD:NAS) is USD$145.59.
What is the dividend yield for Insulet Corporation (PODD:NAS)?
Halo FAQ
Insulet Corporation (PODD:NAS) does not pay a dividend.
What was Insulet Corporation (PODD:NAS) last dividend payment?
Halo FAQ
Insulet Corporation (PODD:NAS) does not pay a dividend.
What is the franking level for Insulet Corporation (PODD:NAS)?
Halo FAQ
Insulet Corporation (PODD:NAS) has a franking level of 0.00%.
In which sector is Insulet Corporation (PODD:NAS) classified?
Halo FAQ
Insulet Corporation (PODD:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Insulet Corporation (PODD:NAS)?
Halo FAQ
The current P/E ratio for Insulet Corporation (PODD:NAS) is 81.70.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial